Division of Pathological Sciences, Department of Pharmacology and Experimental Therapeutics, Kyoto Pharmaceutical University, Yamashina, Japan.
J Physiol Pharmacol. 2009 Dec;60 Suppl 7:183-90.
The effect of subtype-selective phosphodiesterase (PDE) inhibitors on acid secretion was examined in mouse stomachs to investigate which PDE isozymes are involved in the local regulation of this secretion. Male DDY mice were used after 18 h fasting. An isolated stomach was incubated in an organ bath containing buffered solution gassed with 95% O(2)/5% CO(2), while the lumen was perfused with unbuffered solution gassed with 100% O(2). Acid secretion was measured at pH 5.4 using a pH-stat method. Histamine or pituitary adenylate cyclase activating polypeptide (PACAP) was added to the serosal solution. PDE inhibitors were added to the serosal solution 30 min before histamine or PACAP. The secretion of acid in the isolated stomach was increased by histamine or PACAP, and these responses were totally inhibited by famotidine. IBMX alone increased basal acid secretion and significantly enhanced the acid responses to histamine and PACAP. Among the PDE inhibitors tested, only rolipram (PDE4 inhibitor) significantly increased basal acid secretion and potentiated the acid responses to histamine and PACAP. The latter peptide increased histamine release into the medium, and this response was also enhanced by rolipram. Furthermore, rolipram significantly increased cAMP production induced in the isolated stomach by histamine and PACAP. These results suggest that PDE4 is involved in the local regulation of gastric acid secretion via the degradation of cAMP and that the PDE4 inhibitor rolipram increases the secretion of acid by potentiating acid production in parietal cells and enhancing histamine release from enterochromaffin-like cells.
为了研究哪种 PDE 同工酶参与了这种分泌的局部调节,我们在小鼠胃中检查了亚型选择性磷酸二酯酶 (PDE) 抑制剂对胃酸分泌的影响。雄性 DDY 小鼠在禁食 18 小时后使用。将分离的胃在含有缓冲溶液的器官浴中孵育,该缓冲溶液用 95% O(2)/5% CO(2) 气体饱和,而腔用 100% O(2) 气体饱和的未缓冲溶液灌流。使用 pH -stat 法在 pH 5.4 下测量胃酸分泌。在浆膜溶液中加入组胺或垂体腺苷酸环化酶激活肽 (PACAP)。在组胺或 PACAP 加入浆膜溶液 30 分钟前加入 PDE 抑制剂。组胺或 PACAP 可增加分离胃中的胃酸分泌,而这些反应完全被法莫替丁抑制。单独使用 IBMX 会增加基础胃酸分泌,并显着增强对组胺和 PACAP 的胃酸反应。在测试的 PDE 抑制剂中,只有罗利普兰(PDE4 抑制剂)显着增加基础胃酸分泌,并增强对组胺和 PACAP 的胃酸反应。后一种肽增加组胺释放到培养基中,罗利普兰也增强了这种反应。此外,罗利普兰显着增加了组胺和 PACAP 在分离胃中诱导的 cAMP 产生。这些结果表明,PDE4 通过降解 cAMP 参与胃胃酸分泌的局部调节,并且 PDE4 抑制剂罗利普兰通过增强壁细胞的产酸和增强肠嗜铬样细胞释放组胺来增加酸的分泌。